CASI Pharmaceuticals
CASI
#9771
Rank
A$47.03 M
Marketcap
$3.04
Share price
0.46%
Change (1 day)
-12.72%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2024 (TTM): -A$58.54 Million

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are A$28.53 Million. a decrease over its 2023 earnings that were of -A$41.3 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2024

Annual earnings

Year Earnings Change
2024 -A$59.61 Million44.35%
2023 -A$41.3 Million-29.55%
2022 -A$58.61 Million4.43%
2021 -A$56.13 Million-24.56%
2020 -A$74.4 Million4.74%
2019 -A$71.03 Million65.13%
2018 -A$43.02 Million155.07%
2017 -A$16.87 Million13.93%
2016 -A$14.81 Million31.18%
2015 -A$11.29 Million-72.5%
2014 -A$41.03 Million356.62%
2013 -A$8.99 Million-60.55%
2012 -A$22.78 Million218.41%
2011 -A$7.16 Million0.74%
2010 -A$7.11 Million-32.54%
2009 -A$10.53 Million-66.98%
2008 -A$31.88 Million-14.22%
2007 -A$37.16 Million7.04%
2006 -A$34.72 Million27.95%
2005 -A$27.14 Million4.51%
2004 -A$25.97 Million-15.84%
2003 -A$30.85 Million-55.29%
2002 -A$69 Million-34.05%
2001 -A$0.11 Billion31.73%
2000 -A$79.42 Million31.56%
1999 -A$60.37 Million145.56%
1998 -A$24.59 Million76.4%
1997 -A$13.94 Million36.92%
1996 -A$10.18 Million